Chronopharmacology of Anti-Convulsive Therapy
Carregando...
Citações na Scopus
48
Tipo de produção
article
Data de publicação
2013
Editora
SPRINGER
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, v.13, n.4, article ID 339, 15p, 2013
Resumo
Approximately one-third of patients with epilepsy continue to have seizures despite antiepileptic therapy. Many seizures occur in diurnal, sleep/wake, circadian, or even monthly patterns. The relationship between biomarkers and state changes is still being investigated, but early results suggest that some of these patterns may be related to endogenous circadian patterns whereas others may be related to wakefulness and sleep or both. Chronotherapy, the application of treatment at times of greatest seizure susceptibility, is a technique that may optimize seizure control in selected patients. It may be used in the form of differential dosing, as preparations designed to deliver sustained or pulsatile drug delivery or in the form of 'zeitgebers' that shift endogenous rhythms. Early trials in epilepsy suggest that chronopharmacology may provide improved seizure control compared with conventional treatment in some patients. The present article reviews chronopharmacology in the treatment of epilepsy as well as future treatment avenues.
Palavras-chave
Epilepsy, Chronotherapy, Chronopharmacology, Chronopharmacokinetics, Differential dosing, Seizures, Seizure patterns, Diurnal patterns, Closed loops, Melatonin, Light therapy, Dim light melatonin onset, DLMO, Circadian pattern, Suprachiasmatic nucleus, Seizure tracking, Seizure diary, Chronopharmacodynamics, Pharmacokinetics, Pharmacodynamics
Referências
- Acelajado MC, 2012, J AM SOC HYPERTENS, V6, P66, DOI 10.1016/j.jash.2011.09.001
- Assion HJ, 1989, CHRONOPHARMACOLOGY T, P31
- Baraldo M, 2008, EXPERT OPIN DRUG MET, V4, P175, DOI 10.1517/17425255.4.2.175
- Barcia JA, 2009, NEUROTHERAPEUTICS, V6, P337, DOI 10.1016/j.nurt.2009.01.015
- Baxendale S, 2012, EPILEPSY BEHAV, V24, P359, DOI 10.1016/j.yebeh.2012.04.123
- Baxendale S, 2008, EPILEPSY BEHAV, V13, P549, DOI 10.1016/j.yebeh.2008.06.009
- Bazil CW, 1997, EPILEPSIA, V38, P56, DOI 10.1111/j.1528-1157.1997.tb01077.x
- Brigo F, 2012, COCHRANE DB SYST REV, V6
- Bruguerolle B, 1998, CLIN PHARMACOKINET, V35, P83, DOI 10.2165/00003088-199835020-00001
- Cicolin A, 2006, EPILEPSIA, V47, P82, DOI 10.1111/j.1528-1167.2006.00376.x
- Conroy DA, 2012, CHRONOBIOL INT, V29, P35, DOI 10.3109/07420528.2011.636852
- Cortez MA, 1997, PEDIATR NEUROL, V16, P220, DOI 10.1016/S0887-8994(97)00017-9
- Crespel A, 1998, EPILEPSIA, V39, P150, DOI 10.1111/j.1528-1157.1998.tb01352.x
- DEGEN PH, 1994, BIOPHARM DRUG DISPOS, V15, P519, DOI 10.1002/bdd.2510150609
- Lieverse R, 2012, Tijdschr Psychiatr, V54, P527
- Dieker R, 2009, EPILEPSY BEHAV, V50, P2019
- DIJK DJ, 1994, NEUROSCI LETT, V166, P63, DOI 10.1016/0304-3940(94)90841-9
- Dokucu ME, 2005, NEUROPSYCHOPHARMACOL, V30, P2216, DOI 10.1038/sj.npp.1300764
- Durazzo TS, 2008, NEUROLOGY, V70, P1265, DOI 10.1212/01.wnl.0000308938.84918.3f
- Engel J, 2001, EPILEPSIA, V42, P796, DOI 10.1046/j.1528-1157.2001.10401.x
- Etienne-Grimaldi MC, 2008, CLIN PHARMACOL THER, V83, P413, DOI 10.1038/sj.clpt.6100297
- Ezeugo U, 2009, EXPERT OPIN PHARMACO, V10, P485, DOI [10.1517/14656560802694739 , 10.1517/14656560802694739]
- Olano I., 1998, Journal de Pharmacie Clinique, V17, P153
- Falcone T, 2004, CLEVE CLIN J MED S2, V71, pS11
- Fountain NB, 1998, J CLIN NEUROPHYSIOL, V15, P69, DOI 10.1097/00004691-199801000-00009
- Fuse Yuta, 2012, J Circadian Rhythms, V10, P4, DOI 10.1186/1740-3391-10-4
- Placidi F, 2000, NEUROLOGY, V54, pS25
- Gowers W, 1885, EPILEPSY OTHER CHRON
- Guilhoto LMFF, 2011, EPILEPSY BEHAV, V20, P334, DOI 10.1016/j.yebeh.2010.11.017
- Gumz ML, 2010, BBA-GENE REGUL MECH, V1799, P622, DOI 10.1016/j.bbagrm.2010.09.003
- Hallam KT, 2005, NEUROPSYCHOPHARMACOL, V30, P1400, DOI 10.1038/sj.npp.1300739
- Herman ST, 2001, NEUROLOGY, V56, P1453
- Herzog AG, 1997, EPILEPSIA, V38, P1082, DOI 10.1111/j.1528-1157.1997.tb01197.x
- Hofstra WA, 2011, EPILEPSY RES, V94, P158, DOI 10.1016/j.eplepsyres.2011.01.015
- Hofstra WA, 2008, EPILEPSY BEHAV, V13, P438, DOI 10.1016/j.yebeh.2008.06.002
- Hofstra WA, 2009, EPILEPSY BEHAV, V14, P617, DOI 10.1016/j.yebeh.2009.01.020
- Hofstra WA, 2012, EPILEPSY BEHAV, V23, P320, DOI 10.1016/j.yebeh.2011.12.008
- JAESCHKE H, 1985, BIOCHEM PHARMACOL, V34, P1029, DOI 10.1016/0006-2952(85)90606-9
- Johansson AS, 2011, J BIOL RHYTHM, V26, P541, DOI 10.1177/0748730411419775
- Kabuto H, 1998, EPILEPSIA, V39, P237, DOI 10.1111/j.1528-1157.1998.tb01367.x
- Kahane P, 2004, REV NEUROL-FRANCE, V160, pS179
- Kaleyias J, 2011, PEDIATR NEUROL, V45, P109, DOI 10.1016/j.pediatrneurol.2011.03.006
- Karafin M, 2010, SEIZURE-EUR J EPILEP, V19, P347, DOI 10.1016/j.seizure.2010.05.005
- KENNY AM, 1986, NEUROLOGY, V36, P400
- King AB, 2012, ENDOCR PRACT, V18, P382, DOI 10.4158/EP11312.OR
- KLOTZ U, 1984, CLIN PHARMACOKINET, V9, P469
- Kothare SV, 2011, J CLIN NEUROPHYSIOL, V28, P101, DOI 10.1097/WNP.0b013e3182120d30
- LABRECQUE G, 1991, PHARMACOL THERAPEUT, V52, P95, DOI 10.1016/0163-7258(91)90088-4
- Larson AM, 2012, EPILEPSIA, V53, P1162, DOI 10.1111/j.1528-1167.2012.03515.x
- Le S, 2011, EPILEPSY BEHAV, V22, P705, DOI 10.1016/j.yebeh.2011.08.035
- Liu L, 2009, CURR TREAT OPTION N, V11, P242, DOI 10.1007/s11940-009-0028-2
- Loddenkemper T, 2011, NEUROLOGY, V76, P145, DOI 10.1212/WNL.0b013e318206ca46
- MacDonald BK, 2000, ANN NEUROL, V48, P833, DOI 10.1002/1531-8249(200012)48:6<833::AID-ANA3>3.0.CO;2-U
- Singh Rupali, 2012, Recent Pat Drug Deliv Formul, V6, P80
- Manfredini R, 2004, J PEDIATR-US, V145, P838, DOI 10.1016/j.jpeds.2004.06.079
- Oishi Katsutaka, 2006, J Circadian Rhythms, V4, P13, DOI 10.1186/1740-3391-4-13
- MEINARDI H, 1975, EPILEPSIA, V16, P353, DOI 10.1111/j.1528-1157.1975.tb06063.x
- MIN HK, 1966, FED PROC, V25, P917
- Misra UK, 2010, PROG NEUROBIOL, V91, P108, DOI 10.1016/j.pneurobio.2010.01.008
- Molina TA, 2011, CHRONOBIOL INT, V28, P714, DOI 10.3109/07420528.2011.597531
- MOLINACARBALLO A, 1994, PSYCHIAT RES, V52, P273, DOI 10.1016/0165-1781(94)90073-6
- Molina-Carballo A, 2007, NEUROPEDIATRICS, V38, P122, DOI 10.1055/s-2007-985138
- Morrell MJ, 2011, NEUROLOGY, V77, P1295, DOI 10.1212/WNL.0b013e3182302056
- NAKANO S, 1984, CLIN PHARMACOL THER, V36, P271
- NILES LP, 1987, J NEURAL TRANSM, V70, P117
- Nobili L, 2009, EPILEPSIA, V50, P2599, DOI 10.1111/j.1528-1167.2009.02169.x
- Oggier DM, 2010, ENVIRON SCI TECHNOL, V44, P7685, DOI 10.1021/es100980r
- OHDO S, 1989, CHRONOBIOL INT, V6, P229, DOI 10.3109/07420528909056923
- Ohdo S, 2007, DRUG METAB PHARMACOK, V22, P3, DOI 10.2133/dmpk.22.3
- OHDO S, 1991, CHRONOBIOL INT, V8, P35, DOI 10.3109/07420529109063917
- OHDO S, 1992, J CLIN PHARMACOL, V32, P822
- Ohdo S, 1996, JPN J PHARMACOL, V70, P253, DOI 10.1254/jjp.70.253
- PANAYIOTOPOULOS CP, 1994, EPILEPSIA, V35, P285, DOI 10.1111/j.1528-1157.1994.tb02432.x
- PATEL IH, 1982, EPILEPSIA, V23, P283, DOI 10.1111/j.1528-1157.1982.tb06193.x
- Pavlova MK, 2004, EPILEPSY BEHAV, V5, P44, DOI 10.1016/j.yebeh.2003.10.013
- Pavlova MK, 2012, NEUROLOGY, V78, P1488, DOI 10.1212/WNL.0b013e3182553c23
- PETKER MA, 1993, J CLIN PHARM THER, V18, P213, DOI 10.1111/j.1365-2710.1993.tb00616.x
- Poh MZ, 2012, EPILEPSIA, V53, pe93, DOI 10.1111/j.1528-1167.2012.03444.x
- Portaluppi F, 2007, ADV DRUG DELIVER REV, V59, P940, DOI 10.1016/j.addr.2006.10.011
- Quigg M, 1998, ANN NEUROL, V43, P748, DOI 10.1002/ana.410430609
- Quigg M, 2000, ANN NEUROL, V48, P117, DOI 10.1002/1531-8249(200007)48:1<117::AID-ANA19>3.0.CO;2-2
- Ramgopal S, 2012, EPILEPSIA, V53, P1170, DOI 10.1111/j.1528-1167.2012.03499.x
- Raol YH, 2000, EPILEPSIA, V41, P128, DOI 10.1111/j.1528-1157.2000.tb00131.x
- Karwa R, 2001, Drug Metabol Drug Interact, V18, P123
- Ben-Cherif Wafa, 2012, J Circadian Rhythms, V10, P3, DOI 10.1186/1740-3391-10-3
- Reith DM, 2001, CHRONOBIOL INT, V18, P123, DOI 10.1081/CBI-100001176
- Ramgopal S, 2012, SEIZURE-EUR J EPILEP, V21, P535, DOI 10.1016/j.seizure.2012.05.011
- Ruiz-Miyares F, 2000, REV NEUROLOGIA, V30, P925
- Sanchez-Barcelo EJ, 2011, INT J PEDIAT, V2011
- Sato Y, 2004, BRIT J ANAESTH, V92, P859, DOI 10.1093/bja/aeh144
- Shah A, 2012, J NEUROL, V260, P549
- Shah A, 2012, J NEUROL, V26, P549
- Sharkey KM, 2011, SLEEP MED, V12, P685, DOI 10.1016/j.sleep.2011.01.016
- Shea SA, 2012, NEW ENGL J MED, V367, P175, DOI 10.1056/NEJMcibr1204644
- Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b
- SHIRKEY RJ, 1985, EUR J CLIN PHARMACOL, V28, P447, DOI 10.1007/BF00544365
- Sinha S, 2006, J NEUROL NEUROSUR PS, V77, P1076, DOI 10.1136/jnnp.2006.088385
- Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490
- Takiguchi T, 2007, PHARMACOGENET GENOM, V17, P1047, DOI 10.1097/FPC.0b013e3282f12a61
- Tekade AR, 2010, DRUG DELIV, V17, P581, DOI 10.3109/10717544.2010.501460
- Tsioufis C, 2012, AM J HYPERTENS, V25, P279, DOI 10.1038/ajh.2011.236
- TUNON MJ, 1992, ARCH INT PHYSIOL BIO, V100, P83, DOI 10.3109/13813459209035264
- Uthman BM, 2000, ARCH MED RES, V31, P300, DOI 10.1016/S0188-4409(00)00060-6
- VAGNUCCI AH, 1969, J APPL PHYSIOL, V26, P720
- Van Dycke A, 2010, EPILEPSIA, V51, P1721, DOI 10.1111/j.1528-1167.2010.02700.x
- Waterhouse J, 2000, CHRONOBIOL INT, V17, P539, DOI 10.1081/CBI-100101063
- Yalyn O, 2006, EPILEPSY BEHAV, V8, P542, DOI 10.1016/j.yebeh.2005.12.015
- Yegnanarayan R, 2006, CHRONOBIOL INT, V23, P1035, DOI 10.1080/07420520600921112
- Yildiz FG, 2012, J NEUROL SCI, V315, P33, DOI 10.1016/j.jns.2011.12.009
- YOSHIYAMA Y, 1989, J CLIN PHARMACOL, V29, P1048
- Youan BBC, 2004, J CONTROL RELEASE, V98, P337, DOI 10.1016/j.jconrel.2004.05.015
- Zarowski M, 2011, EPILEPSIA, V52, P1076, DOI 10.1111/j.1528-1167.2011.03023.x